Bird & Bird advises uMotif on the deal.uMotif received a $25.5m investment from a fund managed by Athyrium Capital Management. uMotif’s mission is to put patients…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
